STONKWHISPER
← Back to Intel
Insider ActivityTRAW

ORBIMED ADVISORS LLC, 10% Owner at Traws Pharma, Inc., bought $998K of TRAW

Updated Jun 21, 2026
ORBIMED ADVISORS LLC 10% Owner
Traws Pharma, Inc. · $TRAW
$998K Total Value
597,729 Shares Traded
$1.67 Price / Share
1,203,250 Shares Owned After
2026-04-28 Filing Date

Transaction Details

InsiderORBIMED ADVISORS LLC
Title10% Owner
CompanyTraws Pharma, Inc.
TickerTRAW
Transaction TypePurchase
Transaction Date2026-04-16
Shares Traded597,729
Price Per Share$1.67
Total Value$998K
Filed Date2026-04-28
Accession Number0000947871-26-000481

Ownership Context

Shares Owned After Transaction1,203,250
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0000947871-26-000481

Other Insider Trades — TRAW

Other Trades by ORBIMED ADVISORS LLC

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TRAW — Traws Pharma, Inc. →

Track TRAW insider activity in real time on The Wire →

Get alerts when ORBIMED ADVISORS LLC files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 21, 2026 at 07:21 UTC

Want real-time data? Access The Wire for live sentiment tracking.